1,341 results on '"Lee, Nancy Y"'
Search Results
2. Radiation techniques and advancements in nasopharyngeal carcinoma
3. Multi-modality imaging parameters that predict rapid tumor regression in head and neck radiotherapy
4. Osteoradionecrosis Rates After Head and Neck Radiation Therapy: Beyond the Numbers
5. Nomogram to predict risk of early mortality following definitive or adjuvant radiation and systemic therapy for head and neck cancer
6. Radiation oncology for the rhinologist
7. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study
8. International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma
9. Differential use of postoperative psychosocial and physical services among older adults with head and neck cancer
10. Stereotactic Body Radiotherapy for Cancers of the Head and Neck Cancer
11. Nasal Cavity and Paranasal Sinus Tumors
12. Thyroid Cancer
13. Oral Cavity Cancers
14. Major Salivary Glands
15. Hypopharyngeal Carcinoma
16. Larynx Cancer
17. Oropharyngeal Carcinoma
18. Nasopharyngeal Carcinoma
19. Squamous Cell Carcinoma of Unknown Primary in the Head and Neck
20. Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care?
21. Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
22. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
23. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
24. Well-Differentiated Thyroid Cancer: Who Should Get Postoperative Radiation?
25. Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck Cancer
26. Particle Beam Radiation Therapy for Nasopharyngeal Cancer
27. Intensity-Modulated Radiation Therapy for Nasopharyngeal Cancer
28. Intra-treatment hypoxia directed major radiation de-escalation as definitive treatment for human papillomavirus-related oropharyngeal cancer.
29. The combination of patient-specific tumor and HPV sequencing to enable high-sensitivity detection of ctDNA in patients with HPV-associated oropharyngeal carcinoma.
30. Induction chemotherapy effects on very advanced (T3/T4) human papillomavirus-related oropharyngeal cancer for participation in hypoxia-directed major de-escalation (30 Gy) definitive treatment trial.
31. Radiotherapy Plan Quality Assurance in NRG Oncology Trials for Brain and Head/Neck Cancers: An AI-Enhanced Knowledge-Based Approach
32. Reply to A.S. Garden
33. International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic
34. Outcomes following head and neck cancer surgery among older adults as determined by an electronic geriatric assessment
35. Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study
36. Effect of time‐of‐day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trial.
37. Chromosomal instability drives metastasis through a cytosolic DNA response
38. An Analysis of Positron Emission Tomography Maximum Standard Uptake Value Among Patients With Head and Neck Cancer Receiving Photon and Proton Radiation
39. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
40. Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
41. The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines
42. Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.
43. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience
44. The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying—the head and neck cancer model
45. ASO Visual Abstract: Well Differentiated Thyroid Cancer-Who Should get Postoperative Radiation?
46. Salivary Gland Tumors
47. Oropharyngeal Cancer
48. Tumors of the Nasopharynx
49. Oral Cavity Tumors
50. Past, present and future of proton therapy for head and neck cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.